Invenomic Capital Management’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-288,964
| Closed | -$5.27M | – | 145 |
|
|
2022
Q1 | $5.27M | Buy |
288,964
+137,666
| +91% | +$2.51M | 0.56% | 50 |
|
|
2021
Q4 | $4.18M | Buy |
151,298
+19,902
| +15% | +$550K | 0.89% | 38 |
|
|
2021
Q3 | $3.66M | Sell |
131,396
-10,167
| -7% | -$283K | 1.19% | 27 |
|
|
2021
Q2 | $4.15M | Sell |
141,563
-25,073
| -15% | -$735K | 0.99% | 16 |
|
|
2021
Q1 | $5.29M | Buy |
166,636
+31,941
| +24% | +$1.01M | 1.18% | 7 |
|
|
2020
Q4 | $2.8M | Sell |
134,695
-45,169
| -25% | -$940K | 0.71% | 15 |
|
|
2020
Q3 | $2.8M | Buy |
179,864
+52,633
| +41% | +$818K | 1.54% | 7 |
|
|
2020
Q2 | $2.33M | Buy |
127,231
+32,190
| +34% | +$589K | 1.72% | 10 |
|
|
2020
Q1 | $1.47M | Sell |
95,041
-172,699
| -65% | -$2.68M | 1.2% | 26 |
|
|
2019
Q4 | $8.01M | Buy |
+267,740
| New | +$8.01M | 3.22% | 1 |
|